Mediacenter

2024 LogiPharma Benchmarking Report: Building Resilience in Life Science Supply Chain

Market instabilities, geopolitical fragility, and stricter regulations are disrupting life science supply chains. This benchmarking survey, conducted among 100 industry leaders, reveals a critical need for resilient strategies to ensure uninterrupted access to essential medications. To achieve resilient supply chains, leading companies are focusing on three pillars: transparency for earlier disruption detection, rigorous risk management to minimize unexpected event impact, and technology adoption for real-time data, proactive risk assessment, and enhanced quality control. Our survey highlights the urgency for life science companies to rethink their supply chain models.

LogiPharma Asia Benchmarking Report 2023

Today’s pharma decision-makers find themselves facing unprecedented levels of logistics and supply chain complexity with increased regulatory pressures, economic uncertainty, changes in patient behaviour and new technologies adding to the urgency and pressure to digitally transform. This report outlines the key findings on how pharma is adapting to change and building resilience for the future. We uncover the technologies, strategies and key business imperatives being adopted by the industry’s most respected leaders and critical considerations to make during your digital transformation journey

LogiPharma Asia 2022 Post Event Report

LogiPharma is the largest Pharmaceutical Supply Chain event for Asia’s Leaders in Supply Chain, Operations, Logistics, Distribution and Digital Transformation. In June 2022, we had more than 200 attendees join us in Singapore, for 2 days of invaluable networking time, including networking-led roundtables and workshops. Get the full rundown of what makes LogiPharma Asia a sell out summit with this post show report.

AI-Powered Demand Forecasting Future-ready thinking with o9’s digital brain

Supply chains today are being buffeted by change. Consumers are demanding the best product selection at competitive prices, along with rapid delivery and customizability options. This whitepaper will examine how next generation technologies such as machine learning (ML) and artificial intelligence (AI) can significantly increase the accuracy of a business’ forecast, ensuring it survives and thrives instead of being left behind.

Control Towers Sensing and responding to disruptions in the pharma industry

Historically profitable, the pharma sector is currently undergoing a rapid evolution driven by multiple factors that, if left unanswered, will erode critical margins. As pharma and life sciences supply chains become more complex, next-generation planning will be integral in building a digital supply chain operating model that can sense and respond to disruptions in real-time. Read on 

3 Trends Shaping the Life Sciences Industry

The life sciences industry has enjoyed steady growth fueled by research-backed innovation and high profit margins for decades. However, the recent COVID-19 outbreak and subsequent pandemic has made companies rethink everything they thought they knew about their supply chains. This recent paper presented by Kinaxis explores three key trends shaping the future of life sciences supply chains.